| Name | tert-butyl 4-(4-hydroxyphenyl)piperidine-1-carboxylate |
|---|---|
| Synonyms |
4-(1-tert.butyloxycarbonyl-4-piperidinyl)phenol
4-(4-hydroxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester 1-boc-4-(4-hydroxyphenyl)piperidine 1-Boc-4-p-hydroxyphenylpiperidine 1-Boc-4-Hydroxyphenylpiperidine |
| Density | 1.121g/cm3 |
|---|---|
| Boiling Point | 407.3ºC at 760mmHg |
| Molecular Formula | C16H23NO3 |
| Molecular Weight | 277.35900 |
| Flash Point | 200.1ºC |
| Exact Mass | 277.16800 |
| PSA | 49.77000 |
| LogP | 3.44460 |
| Vapour Pressure | 3.24E-07mmHg at 25°C |
| Index of Refraction | 1.541 |
| HS Code | 2933399090 |
|---|
|
~%
149377-19-5 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2004/69256 A1, 2004 ; Location in patent: Page/Page column 32 ; WO 2004/069256 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |